Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,779
Closed -$1.02M 1912
2025
Q4
$1.02M Sell
5,779
-573
-9% -$93.6K 0.01% 964
2025
Q3
$890K Sell
6,352
-1,817
-22% -$246K 0.01% 1072
2025
Q2
$1.03M Sell
8,169
-64,960
-89% -$8.09M 0.01% 968
2025
Q1
$10M Sell
73,129
-21,425
-23% -$3.06M 0.13% 189
2024
Q4
$14.5M Buy
94,554
+37,885
+67% +$6.39M 0.3% 69
2024
Q3
$11M Buy
56,669
+48,964
+635% +$10.2M 0.22% 94
2024
Q2
$1.79M Sell
7,705
-56,061
-88% -$12.2M 0.04% 600
2024
Q1
$13.7M Buy
63,766
+62,429
+4,669% +$14.6M 0.37% 25
2023
Q4
$346K Buy
+1,337
New +$328K 0.01% 1266
2023
Q3
Sell
-2,135
Closed -$608K 1862
2023
Q2
$608K Buy
+2,135
New +$636K 0.02% 934
2022
Q4
Sell
-925
Closed -$247K 1577
2022
Q3
$247K Sell
925
-15,109
-94% -$3.21M 0.01% 1251
2022
Q2
$3.27M Buy
16,034
+15,079
+1,579% +$3.08M 0.14% 196
2022
Q1
$201K Sell
955
-429
-31% -$93.3K 0.01% 1304
2021
Q4
$332K Buy
+1,384
New +$356K 0.02% 834
2021
Q3
Sell
-1,074
Closed -$372K 1110
2021
Q2
$372K Buy
+1,074
New +$325K 0.04% 581

Other funds holding BIIB

Jump Financial's BIIB Position: Q1 2026 in Review

Jump Financial sold out of Biogen (BIIB) in Q1 2026, closing a stake of 5,779 shares — an estimated $1.02M sold.

Jump Financial first reported a position in BIIB in Q2 2021 and held it in 15 quarters. The position peaked at $14.5M in Q4 2024. 1,011 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Jump Financial reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 5,779 Biogen shares in Q1 2026, an estimated $1.02M.
  • Jump Financial first reported a position in Biogen in Q2 2021 and held it in 15 quarters.
  • Jump Financial's Biogen position peaked at $14.5M in Q4 2024.
  • 1,011 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.